Seeking volunteers to use a sun protection app
Many Australians still get sunburnt on a regular basis, despite having good knowledge and sun-protective intentions.
QUT researchers want to assess the impact, if any, apps designed to decrease sunburn may have on peoples’ sun exposure behaviours.
New technologies keeping people sun safe
Dr Elke Hacker was featured in a segment on the children’s science show Scope on channel 11. On Scope scientists and researchers present stories about their research and latest discoveries.
Elke talked about the latest technology and innovation helping to keep people sun safe. Devices range from wearables, to apps and UVR detecting stickers. Elke is currently conducting several studies testing these new devices.
Participate in a pilot study on Sunscreen and Young Children (SAY)
We are conducting a pilot study looking at beliefs and attitudes relating to the use of sunscreen and other sun protective behaviours in young children.
We’re looking for participants that are the parents or guardians of young children between the ages of 2 and 6 years of age to complete an online survey. Please download the attached Participant Flyer for further details.
Participate in a study asking your opinions about the cervical cancer screening program
We are currently conducting a study looking at women’s opinions on cervical cancer screening in Australia.
The National Cervical Screening Program was introduced in 1991 and aims to prevent cervical cancer by detecting early changes in the cervix.
Less invasive treatments for endometrial cancer patients
Endometrial cancer is the most common gynaecological cancer in Australia. Endometrial cancer develops in the lining of the uterus and rates of this cancer are increasing, particularly in women under 40 years of age who are overweight or obese.
Endometrial cancer caught early is very curable. The current standard treatment is surgery (a total hysterectomy), however this results in young women losing their fertility. The feMMe trial aims to treat endometrial cancer less invasively through using a Mirena and metformin. A Mirena is an intra-uterine device commonly used as a contraceptive (the IUD) and metformin is an anti-diabetes drug which has been found to be a potentially powerful anti-cancer drug. In addition, the study will also assess the effect of a weight loss program on early stage endometrial cancer patients. QUT’s Improving Health Outcomes for People Professor Monika Janda is leading the lifestyle component of the feMMe trial.
Lymphedema following gynaecological cancer
Cancer-related lymphedema is a debilitating condition that adversely influences quality of life. Lymphoedema is a potential problematic complication following treatment for cancer and is the accumulation of excessive amounts of fluid resulting in swelling, most commonly in the arms or legs, but can also occur in other parts of the body.
Findings from the LEGS study (Lymphedema Evaluation in Gynaecological Cancer tudy) indicate Lymphedema after gynecological cancer is a common survivorship concern. A clinic-based sample of women (n=408) with gynecological cancer and lymphedema in one or both legs participated in the study. The aim of this study was to assess the prevalence, incidence, and risk factors of lower-limb lymphedema. Improving Health Outcomes for People researcher Prof Sandi Hayes is the lead author of the study published in Gynecologic Oncology. Fifty per cent of women show evidence of lymphedema within 2 years post-gynaecological cancer.
Participate in a survey about sunburn after using sunscreen
We are currently conducting a study looking at sunburn that occurred after the use of sunscreen in Australia. You will be asked to take part in a phone interview or focus group at QUT, Kelvin Grove campus.
If you’d like to assist us, we’re looking for males and females over the age of 18 years to review your experience of sunburn after using sunscreen in Australia.
Seeking research participants: The SKin INnovation (SKIN) research project
Participate in a study looking at skin self-examination and skin cancer diagnosis:
The SKin INnovation (SKIN) research project
Supporting The Cancer Council’s March Charge
Congratulations and well done to our researchers Melissa, Jodie and Megan on their participation in the Cancer Council’s March Charge this year.
The March Charge is a personal fitness challenge where everyone participating sets themselves a walking or running goal for the month of March. The team seeks donations to support their efforts.
Kinder and gentler treatment for uterine cancer
The LACE trial is changing the standard practice in clinical care for women with uterine cancer.
The LACE trial involved 760 patients and 27 surgeons throughout Australia, New Zealand and Hong Kong.
